Trial Details
Not RecruitingBasic Information
| Clinical ID | c5409 |
|---|---|
| Identifier | CTIS2023-507352-72-00 |
| Trial Title | Prospective Analysis of Pharmacokinetic Infliximab data in Paediatric Inflammatory Bowel Disease patients (Pro-RAPID) - NL81536.078.22 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's Disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Remsima 100 mg powder for concentrate for solution for infusion, Product Code:PRD2620214, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: |
Participant Information
| Sponsor | Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, INFANT, TEENAGER |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |